BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
FSK
FS KKR Capital Corp.
There isn't enough reported data to score FSK yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
FSK Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Stable | |
| N/A | |
| N/A |
FSK's profitability is currently stable, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like FSK.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
FSK PE Valuation
FSK has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over FSK on the outlook, with more favorable earnings and revenue expectations.
FSK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Decline | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect FSK's earnings and revenue to decline, with profitability weakening.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over FSK on earnings quality, reporting a profit while its opponent remains loss making.
FSK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.56 | — |
| Q3 2026 | -$1.85 | -293% |
| Q2 2026 | -$1.35 | -275% |
| Q1 2026 | -$1.97 | -204% |
| Q4 2025 | $0.03 | -99% |
| Q3 2025 | $0.96 | -49% |
| Q2 2025 | $0.77 | -66% |
| Q1 2025 | $1.89 | -21% |
| Q4 2024 | $2.08 | -16% |
FSK has swung to a loss: it lost $1.85 per share over the past year, after a profit the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus down 99% for FSK.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
FSK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2022 | $6M | -99% |
| Q1 2022 | $299M | +21% |
| Q4 2021 | $265M | +31% |
| Q3 2021 | $336M | +32% |
| Q4 2020 | $202M | +573% |
FSK's revenue has slid since its 2021 peak: $6M last quarter, down 99% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | -1167% | -1261 points |
| Q1 2022 | 75% | -5.3 points |
| Q4 2021 | 73% | -2.9 points |
| Q3 2021 | 80% | -2 points |
| Q2 2021 | 94% | N/A |
| Q1 2021 | 81% | N/A |
| Q4 2020 | 76% | +142 points |
| Q3 2020 | 82% | N/A |
FSK's operating margin was −1167% last quarter, down 1261 points from the same quarter a year ago, near the bottom of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
FSK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $404M | -43% |
| Q2 2026 | $776M | +619% |
| Q1 2026 | $245M | +$663M |
| Q4 2025 | $195M | -80% |
| Q3 2025 | $707M | +773% |
| Q2 2025 | $108M | -71% |
| Q1 2025 | -$418M | -190% |
| Q4 2024 | $978M | +630% |
FSK's free cash flow was $1.6B over the past year, up 18% from the year before. Free cash flow isn't a meaningful measure for financial services companies like FSK.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over FSK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
FSK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.4% | +4M shares |
| 1 year | +1.5% | +4.2M shares |
| 3 years | +1.5% | +4.2M shares |
| 5 years | -0.3% | -892K shares |
| Available history | +123% | +157M shares |
FSK has 284M diluted shares, up 1.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $70M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
FSK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 14.6x | High |
| Q1 2022 | 6.1x | High |
| Q4 2021 | 5.7x | High |
| Q3 2021 | 5.6x | High |
| Q2 2021 | 5.1x | High |
| Q1 2021 | 6.8x | High |
| Q4 2019 | 16.1x | High |
FSK's net debt is about 15 years of its operating earnings (EBITDA), up from 5.1 years a year ago. Net leverage isn't a meaningful measure for financial services companies like FSK.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
FSK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.7 | Neutral |
| Stochastic | 52.6 | Neutral |
FSK's weekly RSI is 52 (neutral) and its Stochastic is 53 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
FSK PE vs Financial Services Sector
| Metric | FSK | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
FSK has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
FSK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.0 | 5.4% above |
| 20 week MA | $11.3 | 2.7% above |
| 50 week MA | $11.8 | 1.5% below |
| 100 week MA | $15.7 | 26% below |
| 200 week MA | $17.7 | 35% below |
FSK has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over FSK on returns for 2026, with the stronger performance.
FSK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.6 | $16.7 | -32% |
| 2021 | $16.7 | $20.6 | +24% |
| 2022 | $20.6 | $17.8 | -14% |
| 2023 | $17.8 | $20.0 | +13% |
| 2024 | $20.0 | $21.7 | +8.6% |
| 2025 | $21.7 | $14.7 | -32% |
| 2026 YTD | $14.7 | $11.6 | -21% |
FSK has finished lower in three of the last six years. It's down 21% so far in 2026.